These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 11887034
1. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis. Wankiewicz A, Iwan-Zietek I, Kotschy M, Gwieździński Z. Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034 [Abstract] [Full Text] [Related]
6. [Tissue plasminogen activator (t-PA) in aqueous humor of patients with cataract]. Kotschy M, Kałuzny J, Kaniasty M, Zekanowska E, Kropińska E. Klin Oczna; 1996 Mar; 98(3):201-3. PubMed ID: 9019589 [Abstract] [Full Text] [Related]
7. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC. Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164 [Abstract] [Full Text] [Related]
9. [Activation of fibrynolysis in children with chronic B or C hepatitis]. Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M. Pol Merkur Lekarski; 2004 Oct 03; 17(100):316-20. PubMed ID: 15690691 [Abstract] [Full Text] [Related]
10. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Philippé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D. Thromb Haemost; 1991 Mar 04; 65(3):291-5. PubMed ID: 1904655 [Abstract] [Full Text] [Related]
11. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC. Thromb Res; 2008 Mar 04; 121(5):675-80. PubMed ID: 17870147 [Abstract] [Full Text] [Related]
13. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy]. Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M. Pol Merkur Lekarski; 2001 Nov 04; 11(65):414-7. PubMed ID: 11852811 [Abstract] [Full Text] [Related]
15. [Hemostatic disturbances in chronic myeloid leukemia]. Rość D, Kremplewska-Nalezyta E, Gadomska G, Bielis L. Wiad Lek; 2007 Nov 04; 60(3-4):138-42. PubMed ID: 17726865 [Abstract] [Full Text] [Related]
16. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients. Pawlak K, Pawlak D, Mysliwiec M. Thromb Res; 2008 Nov 04; 121(6):787-91. PubMed ID: 17869326 [Abstract] [Full Text] [Related]
17. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Agren A, Wiman B, Schulman S. Blood Coagul Fibrinolysis; 2007 Oct 04; 18(7):657-60. PubMed ID: 17890953 [Abstract] [Full Text] [Related]